Home » Stocks » MTP

Midatech Pharma PLC (MTP)

Stock Price: $1.92 USD -0.02 (-1.03%)
Updated December 3, 4:00 PM EST - Market closed
After-hours: $1.90 -0.02 (-1.04%) Dec 3, 7:16 PM

Stock Price Chart

Key Info

Market Cap 24.21M
Revenue (ttm) 886,842
Net Income (ttm) -13.27M
Shares Out 12.24M
EPS (ttm) -0.85
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day December 3
Last Price $1.92
Previous Close $1.94
Change ($) -0.02
Change (%) -1.03%
Day's Open 1.96
Day's Range 1.82 - 1.96
Day's Volume 342,783
52-Week Range 1.22 - 5.20

More Stats

Market Cap 24.21M
Enterprise Value 17.83M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 12.24M
Float n/a
EPS (basic) n/a
EPS (diluted) -0.85
FCF / Share -4.69
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 136,604
Short Ratio 0.20
Short % of Float n/a
Beta 2.02
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 27.30
PB Ratio 4.01
Revenue 886,842
Operating Income -14.91M
Net Income -13.27M
Free Cash Flow -11.47M
Net Cash 6.38M
Net Cash / Share 0.50
Gross Margin 100.00%
Operating Margin -1,681.45%
Profit Margin -1,496.30%
FCF Margin -1,293.62%
ROA -32.28%
ROE -151.13%
ROIC -188.20%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $1.92
Target: 1,575
*Average 12-month USD price target from 1 stock analysts.

Financial Performance

Financial numbers in millions GBP.

Financial Overview

Revenue Growth-65.22%95.96%-25.25%-3.78%775.8%6.8%-
Gross Profit0.671.940.991.321.310.160.15
Operating Income-11.33-11.82-13.28-9.65-12.92-9.69-4.50
Net Income-10.09-15.03-16.06-20.16-10.10-8.82-4.08
Shares Outstanding12.2412.229.746.696.692.861.03
Earnings Per Share-2.75-24.60-31.30-14.00-9.00-24.50-17.75
Operating Cash Flow-8.41-14.81-14.41-14.74-13.07-6.25-5.02
Capital Expenditures-0.31-0.22-0.71-1.35-0.92-1.03-0.05
Free Cash Flow-8.72-15.03-15.12-16.08-13.99-7.28-5.07
Cash & Equivalents10.932.3413.2017.6116.1830.332.39
Total Debt6.081.256.552.161.951.983.37
Net Cash / Debt4.851.096.6615.4514.2328.35-0.98
Book Value19.5616.9234.6845.7246.8941.990.76
Numbers in millions GBP, except per-share numbers.

Company Profile

Company Details

Full Name Midatech Pharma PLC
Employees 65

Stock Information

Ticker Symbol MTP
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: MTP


Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTD201, a long acting dose of Octreotide for the treatment of acromegaly and neuroendocrine tumors; and MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma. It also offers drug delivery platforms, such as Q-Sphera, a microencapsulation and polymer-depot sustained release drug delivery platform; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. Midatech Pharma plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.